Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Campylobacter vaccine completes phase II trial

June 17, 1999

Stable immunomodulators related to Imreg-1 developed at BioChem Pharma

June 17, 1999

U.S. patent granted for conjugate vaccine against group B streptococci

June 17, 1999

Aviron completes FluMist bridging study

June 16, 1999

NAVA's novel meningococcal vaccine elicits immunologic memory

June 16, 1999

New PTK inhibitors developed at Bristol-Myers Squibb

June 15, 1999

FDA approves initiation of clinical trial of strep vaccine

June 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...